Blood-based microRNA profiling in patients with cardiac amyloidosis.

Anselm A DerdaAngelika PfanneChristian BärKatharina SchimmelPeter J KennelKe XiaoP Christian SchulzeJohann BauersachsThomas Thum

Published in: PloS one (2018)

MiR-339-3p was increased in blood of patients with senile cardiac amyloidosis. Therefore, miR-339-3p is a potential candidate as biomarker for senile cardiac amyloidosis in future studies. Larger patient cohorts should be investigated.

Keyphrases

left ventricular
case report
heart failure
single cell
current status
human health
case control
single molecule